Engineering synthetic TAL effectors with orthogonal target sites

Area of Science:

• Synthetic biology
• Molecular biology
• Bioengineering

Background:

• Transcriptional activator-like effectors (TALEs) are crucial for engineering biological circuits due to their customizable DNA targeting.
• Current TALE applications are limited by DNA recognition degeneracy, hindering precise control.
• Developing TALEs with improved specificity is essential for advancing gene regulation technologies.

Purpose of the Study:

• To computationally design highly specific TALE DNA-binding domains.
• To overcome the challenge of degeneracy in TALE-DNA interactions.
• To engineer precise gene activation and repression systems using synthetic TALEs.

Main Methods:

• Development of a novel algorithm for designing TALEs with enhanced DNA binding specificity.
• In silico design of 180 TALEs targeting 20 bp sequences with at least 3 nt mismatches from other sequences in human promoters.
• Experimental validation of designed TALE activators and repressors, including combination with shRNAs.

Main Results:

• Successfully designed and validated synthetic TALE activators demonstrating specific transcriptional activation.
• Demonstrated that designed TALEs do not activate off-target reporters with genomic-like mismatches or endogenous genes.
• Engineered TALE repressors, in combination with shRNAs, achieved near-complete gene expression repression.

Conclusions:

• The developed algorithm enables the design of highly specific TALEs, overcoming previous limitations.
• These engineered TALEs provide precise tools for constructing sophisticated biological circuits.
• The findings pave the way for advanced applications in synthetic biology, medicine, and fundamental research.